Collaborations (Tables)

9 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and contract liabilities for the nine months ended September 30, 2024 (in thousands):

	Balance at December 31, 2023		Additions		Deductions			Balance at September 30, 2024
Accounts receivable and contract assets:
Billed receivables - Sanofi	$	15,000	$	7,496	$	(22,496	)	$	—
Unbilled receivables - Sanofi		3,762		5,051		(7,496	)		1,317
Total accounts receivable and contract assets	$	18,762	$	12,547	$	(29,992	)	$	1,317
Contract liabilities:
Deferred revenue - Sanofi		54,651		5,051		(39,678	)		20,024
Total contract liabilities	$	54,651	$	5,051	$	(39,678	)	$	20,024